The University of Bari Aldo Moro is a higher education institution in Bari, Apulia, in Southern Italy. The University of Bari was founded in 1925. It is a state-supported university which is divided into 12 faculties.

During the past decade, University of Bari conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 3 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Bari" #1 sponsor was "University of Bari" with 3 trials, followed by "Allergan" with 1 trials sponsored, "CNS Pharmaceuticals, Inc." with 1 trials sponsored, "Emory University" with 1 trials sponsored and "Federico II University" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Bari" #1 collaborator was "Abbott Diagnostics Division" with 1 trials as a collaborator, "Antonio Di Mauro" with 1 trials as a collaborator, "Associazione Medici Diabetologi (AMD)" with 1 trials as a collaborator, "Associazione Nazionale Medici Cardiologi Ospedalieri" with 1 trials as a collaborator and "BUPA Foundation" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "University of Bari" are "Autism Spectrum Disorder" (1 trials), "Benign Prostatic Hyperplasia (BPH)" (1 trials), "Blepharospasm" (1 trials), "Cardiac Surgery" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "University of Bari" in a lesser frequency.

Most popular intervention types in "University of Bari" are "Drug" (6 trials), "Dietary Supplement" (3 trials), "Other" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Berubicin" (1 trials), "Blood sampling" (1 trials), "CEA, CAS" (1 trials) and "L.Reuteri" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Bari" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Bari". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in University of Bari, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Bari, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".